Curated News
By: NewsRamp Editorial Staff
July 29, 2026

Datavault AI Expands Blockchain Health Data Licensing Deal with DataMeds

Discuss on Substack Discuss on Telegram
Original Source

TLDR

  • Datavault AI gains 19.9% equity in DataMeds, expanding its blockchain healthcare footprint for competitive advantage.
  • The amended agreement replaces preferred shares with common stock to accelerate deployment of Datavault AI's technology into healthcare.
  • Patient-controlled health data access and monetization empower individuals, improving healthcare transparency and personal wellness.
  • PharmacyChain blockchain technology now extends to wearable devices and remote patient monitoring for healthspan applications.

Impact - Why it Matters

This news matters because it signals a shift toward patient-controlled health data management, potentially giving individuals more authority over their medical information and the ability to monetize it. By integrating blockchain and AI into healthcare, the partnership could enhance data security, streamline medical logistics, and enable new models for remote patient monitoring. For investors, Datavault AI's expansion into the lucrative health and wellness market presents growth opportunities, while patients may benefit from improved data access and personalized care. The move also highlights the growing trend of tokenizing real-world assets in healthcare, which could transform how health data is valued and exchanged.

Summary

Datavault AI (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc. (NASDAQ: MEDS) to extend its PharmacyChain blockchain technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications. The enhanced partnership aims to empower patient-controlled health data access, monetization, and real-world asset tokenization across diverse environments including pharmacies, medical facilities, laboratories, and wearable devices. This expansion leverages a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring, marking a significant step in Datavault AI's foray into the healthcare sector.

Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS' outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares initially planned for tax optimization. The companies stated that this agreement accelerates the deployment of Datavault AI's technology into healthcare, targeting opportunities within the rapidly expanding global health and wellness market. By enabling new patient-controlled data transaction models, the collaboration aims to give individuals greater control over their health data while creating new revenue streams.

Datavault AI is a leader in AI-driven data experiences, valuation, and monetization within the Web 3.0 environment. Its cloud-based platform offers solutions through its Acoustic Sciences and Data Sciences divisions. The Acoustic Sciences division features technologies like WiSA, ADIO, and Sumerian for spatial and multichannel wireless sound transmission. The Data Science division leverages Web 3.0 and high-performance computing for data perception, valuation, and secure monetization. The company's platform serves multiple industries including healthcare, sports, entertainment, fintech, and more. For more details, visit the full press release at https://ibn.fm/vBAxH.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Datavault AI Expands Blockchain Health Data Licensing Deal with DataMeds

blockchain registration record for this content.